Mogamulizumab-kpkc Intravenous and Paroxetine Controlled-Release Tablets
Determining the interaction of Mogamulizumab-kpkc Intravenous and Paroxetine Controlled-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: paroxetine
Brand name: Brisdelle, Paxil, Paxil CR, Pexeva
Synonyms: Paroxetine, PARoxetine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Paroxetine ER
- Mogamulizumab-kpkc Intravenous-Paroxetine Hydrochloride
- Mogamulizumab-kpkc Intravenous-Paroxetine Oral Suspension
- Mogamulizumab-kpkc Intravenous-Paroxetine Suspension
- Mogamulizumab-kpkc Intravenous-Paroxetine Tablets
- Mogamulizumab-kpkc Intravenous-Parsabiv
- Paroxetine Controlled-Release Tablets-Molindone
- Paroxetine Controlled-Release Tablets-Mometasone (Oral Inhalation)
- Paroxetine Controlled-Release Tablets-Mometasone and Formoterol
- Paroxetine Controlled-Release Tablets-Mometasone and formoterol Inhalation
- Paroxetine Controlled-Release Tablets-Mometasone Cream
- Paroxetine Controlled-Release Tablets-Mometasone Furoate